Tag: FDA

Health Implications of Poor COVID-19 mRNA Testing: Miscarriage, Vision Loss, Immunotoxicity

In this series, “Promise or Peril: Alarming COVID-19 mRNA Vaccine Issues,” we explore how the introduction of mRNA technology lacked an adequate regulatory framework, setting the stage for serious adverse events and other concerns related to inadequate safety testing of lipid nanoparticles, spike protein, and residual DNA and lipid-related impurities as well as truncated/modified mRNA…


[ATL:NOW] Sen. Ron Johnson: EcoHealth Grant Reinstated; COVID Corruption ‘On a Grand Scale’

Sen. Ron Johnson (R-Wis.) has been a vocal critic of COVID protocols since early on in the pandemic. “As much as they said they were ‘the science’, they weren’t. And they didn’t follow the science. They ignored it. They had an agenda. They had their solutions, they had their response, and don’t let any facts…


[ATL:NOW PREMIERING 7:30PM ET] Sen. Ron Johnson: EcoHealth Grant Reinstated; COVID Corruption ‘On a Grand Scale’

Sen. Ron Johnson (R-Wis.) has been a vocal critic of COVID protocols since early on in the pandemic. “As much as they said they were ‘the science’, they weren’t. And they didn’t follow the science. They ignored it. They had an agenda. They had their solutions, they had their response, and don’t let any facts…


Judge Orders FDA to Speed Up Release of COVID-19 Vaccine Trial Data From 23.5 Years to Just 2

A federal judge in Texas this week ordered the Food and Drug Administration (FDA) to make public data it relied on to license COVID-19 vaccines—Moderna’s for adults and Pfizer’s for children—at an accelerated rate, requiring all documents to be made public by mid-2025 rather than, as the FDA wanted, over the course of around 23.5…


FDA Committee Recommends Epinephrine Nasal Spray for Severe Allergic Reactions

The Food and Drug Administration’s Pulmonary-Allergy Drugs Advisory Committee voted on May 11 to recommend an epinephrine nasal spray product for the treatment of severe allergic reactions, including anaphylaxis. The 22-member advisory committee voted 16–6 to recommend approval of the 2 milligram epinephrine saline-based spray, marketed as Neffy, for adults. It voted 17–5 to recommend the…


LIVE NOW: House Oversight Committee Hearing on ‘Infant Formula Shortage’

U.S. House Oversight Committee holds a hearing on “Infant Formula Shortage” as part II of oversight FDA at 2:00 p.m. ET on May 11. Susan T. Mayne, Ph.D. Director, Center for Food Safety and Applied Nutrition of the U.S. Food and Drug Administration, will testify. ‘ …


House Oversight Committee Hearing on ‘Infant Formula Shortage’

U.S. House Oversight Committee holds a hearing on “Infant Formula Shortage” as part II of oversight FDA at 2:00 p.m. ET on May 11. Susan T. Mayne, Ph.D. Director, Center for Food Safety and Applied Nutrition of the U.S. Food and Drug Administration, will testify. ‘ …


Florida Surgeon General Hits Back at FDA, CDC Over COVID-19 Vaccine Safety

U.S. officials are gaslighting the public about COVID-19 vaccine safety, a top Florida public health official says, as he urged the officials to investigate concerns with the shots. “Your ongoing decision to ignore many of the risks associated with mRNA COVID-19 vaccines, alongside your efforts to manipulate the public into thinking they are harmless, have…


‘Misinformation’ Will End Once the FDA Releases These Records, Says Top US Vaccine Investigator

FORT WORTH, TEXAS—Death records of Americans and their vaccination status must be released to the public in order to end the “ambiguity” that surrounds the safety of COVID-19 vaccines, said Steve Kirsch, the country’s top independent vaccine investigator. “If it’s really safe and effective, why would [the government] keep that data hidden? Why wouldn’t they…


LIVE 9:30 AM ET: FDA, HHS Advisory Board Meeting on Nonprescription Birth Control Pill (Day 2)

The Food and Drug Administration (FDA) and Department of Health and Human Services hold a public advisory committee meeting of the Nonprescription Drugs Advisory Committee and the Obstetrics, Reproductive and Urologic Drugs Advisory Committee from 9:30 a.m. to 1:30 p.m. ET on May 10. The committees discuss supplemental new drug application (sNDA) 017031/S-041, for OPILL…